For blood pressure, the foundation is medical care plus DASH-level diet work; supplements are small levers on top.Stack-kit editorial
Pick by risk, not hype. Magnesium glycinate is the gentlest first move, dietary potassium can be the bigger lever when intake is low, and CoQ10 is the most optional of the three unless statin use or mitochondrial-support logic makes it worth the cost. None replaces prescribed blood pressure medication.
The comparison table
| Option | Best for | Dose | Evidence | Caveat |
|---|---|---|---|---|
| Magnesium glycinate | A low-friction foundational trial, especially if intake is low or cramps/sleep tension coexist | 300-400 mg elemental magnesium per day, usually with the evening meal | Zhang et al. 2016 pooled 34 RCTs and found systolic pressure fell 2.00 mmHg and diastolic 1.78 mmHg at a median 368 mg/day. | Modest effect. Avoid casual use with eGFR under 30 or potassium-sparing diuretics unless your clinician is guiding it. |
| Dietary potassium / potassium-chloride salt substitute | Low-potassium, high-sodium diets and people building a DASH-style base | Aim for the dietary gap first; source protocol uses 1,000-1,500 mg/day additional potassium via salt substitute | Filippini et al. 2020 found 90 mmol/day potassium, about 3,500 mg, reduced systolic pressure by 6.8 mmHg in hypertensive subjects. | Real hyperkalemia risk with kidney disease, ACE inhibitors, ARBs, or potassium-sparing diuretics. Prescriber and labs first. |
| CoQ10 ubiquinol | Adults on statins or people who want the mitochondrial/endothelial layer after higher-leverage moves | 100-200 mg/day ubiquinol with a fat-containing meal | Rosenfeldt et al. 2007 reported large reductions, but Ho et al. 2016 Cochrane found no significant effect; honest read is mixed and modest. | Weakest evidence of these three. Avoid unsupervised use on warfarin because CoQ10 can lower INR. |
Start with the base layer
Hypertension is a medical condition, not a supplement-shopping problem. The source protocol is explicit: this stack complements prescribed antihypertensive therapy and should be run past your prescriber, especially if you already take ACE inhibitors, ARBs, diuretics, beta blockers, anticoagulants, or statins. Home monitoring matters too. Use a validated cuff, measure at consistent times, and do not judge anything on a single reading.
The larger lever remains the dietary pattern: DASH, sodium reduction, weight management where relevant, zone-2 cardio, and sleep. Potassium is partly powerful because it is a diet lever hiding inside a mineral comparison. If the rest of the day stays sodium-heavy and low-fiber, a capsule-sized intervention is not going to carry the whole system.
When to skip or call your prescriber
Potassium is the sharp edge. If kidney function is reduced, or if you use an ACE inhibitor, ARB, spironolactone, eplerenone, amiloride, or triamterene, do not self-direct potassium chloride. Ask about a basic metabolic panel before starting and again 4-6 weeks later. Magnesium is usually gentler, but reduced renal function changes that risk. CoQ10 belongs in the same conversation if you take warfarin, because INR can move. And across all three: do not stop a blood pressure medication because a supplement lowered a few home readings. That adjustment belongs to your prescriber.
Evidence notes
- Zhang et al., Hypertension 2016: 34 RCTs, N=2,028; magnesium lowered systolic pressure by 2.00 mmHg and diastolic by 1.78 mmHg.
- Filippini et al., Journal of the American Heart Association 2020: dose-response meta-analysis across 32 trials found larger potassium effects in hypertensive subjects.
- Rosenfeldt et al. 2007 and Ho et al. 2016: CoQ10 moved from early large-effect claims to a more mixed Cochrane-era evidence base.
Where to go next
Use this page to make the choice. Use the protocol pages when you are ready to build the stack, sequence the dose, and see what Stack-kit would actually buy.
FAQ
Which blood pressure supplement should I try first?
If medication safety is straightforward, magnesium glycinate is the gentlest first trial. Potassium can move more pressure when intake is low, but kidney disease and ACE inhibitors, ARBs, or potassium-sparing diuretics make it a prescriber-guided move.
Can potassium supplements be dangerous?
Yes. Potassium can cause hyperkalemia when kidney function is reduced or when it is combined with ACE inhibitors, ARBs, or potassium-sparing diuretics. Use dietary potassium first and get a basic metabolic panel if your prescriber recommends potassium chloride.
Can this stack replace blood pressure medication?
No. The source protocol frames the stack as a complement to prescribed antihypertensive therapy. Do not stop or adjust blood pressure medicine without your prescriber, and monitor at home with a validated cuff.
Affiliate disclosure
Stack-kit may earn affiliate commission when readers buy through protocol recommendations. These comparison and answer pages do not invent product links; they route to the full protocols where the current brand calls live.
We do not sell our own SKUs. We do not have a house brand, a premium tier, or a founder's discount. If a better evidence-backed option replaces a recommendation, the protocol changes.